Cara Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cara Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Cara Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.99M, a 79.3% increase year-over-year.
  • Cara Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$85.6M, a 28.8% increase year-over-year.
  • Cara Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$121M, a 38.8% decline from 2022.
  • Cara Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$87.5M, a 1.74% increase from 2021.
  • Cara Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$89.1M, a 1754% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$85.6M -$5.99M +$22.9M +79.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$108M -$17.3M +$15M +46.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$124M -$29.7M -$2.02M -7.29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$121M -$32.6M -$1.3M -4.15% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 -$120M -$28.9M -$5.05M -21.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$115M -$32.3M -$27.9M -623% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$87.3M -$27.7M +$261K +0.94% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$87.5M -$31.3M +$2.22M +6.61% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 -$89.8M -$23.8M -$22.7M -2021% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$67M -$4.47M +$26.4M +85.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$93.4M -$27.9M -$4.35M -18.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$89.1M -$33.5M -$112M -143% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $22.7M -$1.12M +$15.9M +93.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $6.83M -$30.9M -$4.99M -19.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $11.8M -$23.6M +$6.44M +21.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $5.39M $78.3M +$108M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$103M -$17M +$17.4M +50.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$120M -$25.9M -$1.74M -7.22% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$119M -$30M -$6.87M -29.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$112M -$30M -$7.99M -36.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$104M -$34.4M -$14M -68.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$89.7M -$24.1M -$6.33M -35.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$83.4M -$23.1M -$6.01M -35.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$77.4M -$22M -$7.41M -50.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$70M -$20.5M -$7.51M -58% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$62.5M -$17.8M -$8.18M -84.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$54.3M -$17.1M +$5.2M +23.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$59.5M -$14.6M +$7.74M +34.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$67.2M -$13M -$1.18M -10% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$66M -$9.63M +$3.69M +27.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$69.7M -$22.3M -$11.3M -103% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$58.4M -$22.3M -$12.6M -129% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 -$45.8M -$11.8M -$6.76M -135% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$39.1M -$13.3M -$7.59M -132% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$31.5M -$11M -$6.27M -133% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$25.2M -$9.73M -$5.39M -124% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 -$19.8M -$5.01M +$1.59M +24.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$21.4M -$5.73M -$2.02M -54.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$19.4M -$4.72M -$1.3M -37.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$18.1M -$4.34M -$2.23M -106% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$15.8M -$6.6M -$3.06M -86.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$12.8M -$3.71M -$10.6M -154% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$2.15M -$3.42M -$1.91M -127% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$237K -$2.11M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 -$3.54M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $6.92M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$1.51M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.